1.Application of reserved jejunal feeding tube during postoperative chemotherapy of gastric cancer
Hanjun MA ; Sanrong LI ; Hansheng JIN ; Jian SUN ; Xianlin SHU ; Yalin YE ; Qingquan LV ; Qi WEI
Chinese Journal of Postgraduates of Medicine 2008;31(20):30-32
Objective To evaluate the effects of reserved jejunal feeding tube during postoperative chemotherapy of gastric cancer. Methods Forty-two patients with gastric cancer underwent radical gastrectomy and going to adjuvant chemotherapy,conventional placed jejunal feeding tube. All of the patients weredivided into group A and group B randomly by pathological staging and tumor site, group A reserved jejunal feeding tube and received enteral nutrition through the tube during chemotherapy, and group B non-reservedjejunal feeding tube and been given daily diet,compared nutrition and immune indicators of two groups beforeand after chemotherapy ,compared the rate of vomiting,and observed complications long-term reserved jejunal feeding tube. Results In post-chemotherapy,nutrition and immune indicators of group A were betterthan those of group B, the difference was statistically significant (P<0.05) ,the rate of vomiting in group Awas significantly lower than that of in group B (X2= 9.75, P<0.01 ), no serious complieations occurred forlong-term reserved jejunal feeding tube. Conclusions Reserved jejunal feeding tube and received enteralnutrition through the tube during postoperative chemotherapy of gastric cancer can significantly improve the nutritional and immune status. It is safe and reliable, worth promoting.
2. Expert consensus guidelines on clinical use of Xiyanping injection for acute infectious diseases
Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO
Asian Pacific Journal of Tropical Medicine 2020;13(4):152-161
Xiyanping injection, a traditional Chinese medicine injection made of andrographolide sulfonate, consisting of well-defined ingredients with antiviral, antibacterial, anti-inflammatory and antipyretic efficacy, has been widely used for treating infectious diseases of respiratory and digestive systems. However, its wide applications may easily lead to unreasonable clinical medication. In order to guide the precise clinical application and rational use of Xiyanping injection, experts in related fields conducted systematically literature review, evaluated and deliberated the application of Xiyanping injection in treating acute infectious diseases using evidence-based medicine method, and jointly drafted the consensus to summarize types of acute infectious diseases in children and adults that can be treated with Xiyanping injection, and recommend the intervention time, usage and dosage, course of treatment and combined medication of the injection. Besides, the consensus elucidates the safety, precautions and contraindications of the injection, so as to provide guidance for clinical use.